FdaApplication
NDA 209354
Identifiers
- fda_app_no: NDA209354
Properties
| Property | Value |
|---|---|
| applicant_name | BAUSCH HEALTH AMERICAS INC |
| application_type | NDA |
| approval_date | 2019-04-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DUOBRII | HALOBETASOL PROPIONATE; TAZAROTENE | 0.01%;0.045% | LOTION;TOPICAL |
1 product